Benzinga - Tue, 13 Apr 2021 10:04:03 -0400
Benzinga - Tue, 30 Mar 2021 10:20:55 -0400
Benzinga - Fri, 26 Mar 2021 04:59:29 -0400
Benzinga - Thu, 25 Mar 2021 13:00:54 -0400
Benzinga - Thu, 25 Mar 2021 12:05:07 -0400
Benzinga - Thu, 25 Mar 2021 11:01:47 -0400
Benzinga - Thu, 25 Mar 2021 08:08:47 -0400
Benzinga - Thu, 25 Mar 2021 07:03:20 -0400
load more
Sector: Health Care.Industry: Pharmaceuticals
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health, including hormone-free, woman-controlled contraception and protection from certain sexually transmitted infections (STIs). The company's product, Phexxi (lactic acid, citric acid and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy. The company is also evaluating its investigational drug candidate EVO100 vaginal gel for the prevention of urogenital transmission of Chlamydia trachomatis infection (chlamydia) and Neisseria gonorrhoeae infection (gonorrhea) in women.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-05
REV
Q4 2020Est.ActualSurprise
EPS-0.360-0.500 -0.1400
REV1.690M168.000K-1.522M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
EVFMEvofem Biosciences0.61%164.4M

Evofem Biosciences Company Questions & Answers

Q

How do I buy Evofem Biosciences (EVFM) stock?

A

You can purchase shares of Evofem Biosciences (NASDAQ: EVFM) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Evofem Biosciences's (EVFM) main competitors?

A

Other companies in Evofem Biosciences’s space includes: Onconova Therapeutics (NASDAQ:ONTX), Satsuma Pharmaceuticals (NASDAQ:STSA) and SCYNEXIS (NASDAQ:SCYX).

Q

What is the target price for Evofem Biosciences?

A

The latest price target for Evofem Biosciences (NASDAQ: EVFM) was reported by HC Wainwright & Co. on 2021-03-08. The analyst firm set a price target for 7.00 expecting EVFM to rise to within 12 months (a possible 326.83% upside). 6 analyst firms have reported ratings in the last year.

Q

How much is Evofem Biosciences (EVFM) stock ?

A

The stock price for Evofem Biosciences (NASDAQ: EVFM) is $1.64 last updated Today at 8:00:02 PM.

Q

When is the next Evofem Biosciences (EVFM) dividend?

A

There are no upcoming dividends for Evofem Biosciences.

Q

When is Evofem Biosciences (NASDAQ:EVFM) reporting earnings?

A
Evofem Biosciences’s Q1 earnings are confirmed after-market from now on May 5, 2021.
Q

When is the upcoming split for EVFM?

A

There is no upcoming split for Evofem Biosciences.